#MY OPZELURA MOMENT (RUXOLITINIB) CREAM 1.5%

Serial Number 98150505
731

Registration Progress

Application Filed
Aug 25, 2023
Under Examination
Apr 23, 2024
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Oct 23, 2025 83 days

Trademark Image

#MY OPZELURA MOMENT (RUXOLITINIB) CREAM 1.5%

Basic Information

Serial Number
98150505
Filing Date
August 25, 2023
Published for Opposition
February 27, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
Apr 15, 2025
Application
Pending
Classes
041 044

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
83 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
October 23, 2025
Extension Available
Until April 23, 2025

Application History

22 events
Date Code Type Description Documents
Apr 16, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 15, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 18, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 17, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 17, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 17, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 17, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 24, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 29, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 041
Providing online, non-downloadable journals, blogs and electronic newsletters in the field of dermatology, health and well-being
Class 044
Providing health care information by global computer networks; Providing health information via a website, namely, patient experiences of dermatological disorders

Additional Information

Design Mark
The mark consists of a circle with the word "OPZELURA" above the words "(RUXOLITINIB) CREAM 1.5%" above a short line all above the word "MOMENT" curved like the circle. To the right of the circle is a smaller circle with the "MY" inside and a "#" overlapping the circle at the top. At the top of the large circle is a smear of cream.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
POUND MY OPZELURA MOMENT RUXOLITINIB CREAM ONE POINT FIVE PERCENT

Classification

International Classes
041 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"(RUXOLITINIB) CREAM 1.5%"